Next Article in Journal
(2S)-[3-(Anthracen-9-yl)-4,5-dihydroisoxazol-5-yl]methyl 2-[(tert-butoxycarbonyl)amino]propanoate
Previous Article in Journal
Open AccessShort Note


Kagawa School of Pharmaceutical Sciences, Tokushima Bunri University, 1314-1 Shido, Sanuki, Kagawa 769-2193, Japan
Author to whom correspondence should be addressed.
Molbank 2014, 2014(4), M836;
Received: 6 August 2014 / Accepted: 23 October 2014 / Published: 28 October 2014
The title compound, N'-[2-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin- 10(2H)-yl)ethylidene]-4-nitrobenzohydrazide (1), was obtained by the reaction of formylmethylflavin and p-nitrobenzohydrazide. The product 1 inhibited the DNA binding of nuclear factor-κB, and was characterized by 1H-NMR, 13C-NMR, electrospray ionization mass spectrometry, elemental analysis, IR and UV. View Full-Text
Keywords: flavin; Nuclear factor-κB; inhibitor; DNA binding flavin; Nuclear factor-κB; inhibitor; DNA binding
Show Figures

Graphical abstract

MDPI and ACS Style

Morikawa, M.; Kino, K.; Asada, E.; Katagiri, K.; Mori-Yasumoto, K.; Suzuki, M.; Kobayashi, T.; Miyazawa, H. N'-[2-(7,8-Dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)ethylidene]-4-nitrobenzohydrazide. Molbank 2014, 2014, M836.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Only visits after 24 November 2015 are recorded.
Back to TopTop